Cabaletta Bio Inc (NASDAQ:CABA) shares, rose in value on Friday, July 11, without any change to the previous day’s close as strong demand from buyers drove the stock to $1.74.
Actively observing the price movement in the last trading, the stock closed the session at $1.74, falling within a range of $1.695 and $1.78. The value of beta (5-year monthly) was 2.793. Referring to stock’s 52-week performance, its high was $8.77, and the low was $0.99. On the whole, CABA has fluctuated by -25.96% over the past month.
With the market capitalization of Cabaletta Bio Inc currently standing at about $156.50 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-15.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 4.17M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CABA’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of CABA currently trading nearly 1.84% and 1.26% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.95, while the 7-day volatility ratio is showing 8.66% which for the 30-day chart, stands at 9.59%. Furthermore, Cabaletta Bio Inc (CABA)’s beta value is 2.74.
A comparison of Cabaletta Bio Inc (CABA) with its peers suggests the former has fared considerably weaker in the market. CABA showed an intraday change of 0.00% in last session, and over the past year, it shrunk by -23.35%%.
Data on historical trading for Cabaletta Bio Inc (NASDAQ:CABA) indicates that the trading volumes over the past 10 days have averaged 2.49 and over the past 3 months, they’ve averaged 2.12 million. According to company’s latest data on outstanding shares, there are 89.94 million shares outstanding.
Nearly 9.03% of Cabaletta Bio Inc’s shares belong to company insiders and institutional investors own 43.69% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.47 million shares as on 2025-06-13, resulting in a short ratio of 1.92. According to the data, the short interest in Cabaletta Bio Inc (CABA) stood at 732.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 5.52 million. The stock has fallen by -77.63% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CABA stock heading into the next quarter.
